The United States of America; as represented by the Secretary; Department of Health and Human Services
发明人:
McGavern, Dorian B.,Roth, Theodore
申请号：
AU2013219799
公开号：
AU2013219799A1
申请日:
2013.02.05
申请国别(地区):
AU
年份:
2014
代理人:
摘要：
Disclosed is a method of treating or preventing a disease or disorder of the central nervous system (CNS) in a patient comprising administering transcranially, for example, directly to the skull, an effective amount of an anti-inflammatory agent to the patient. Examples of the anti-inflammatory agent include glutathione and inhibitors of purinergic receptors such as P2X
